β-catenin (CTNNB1) mutation and LEF1 expression in sinonasal glomangiopericytoma (sinonasal-type hemangiopericytoma)

被引:15
|
作者
Suzuki, Yuka [1 ]
Ichihara, Shu [2 ]
Kawasaki, Tomonori [2 ]
Yanai, Hiroyuki [3 ]
Kitagawa, Satoshi [4 ]
Shimoyama, Yoshie [1 ]
Nakamura, Shigeo [1 ]
Nakaguro, Masato [1 ]
机构
[1] Nagoya Univ Hosp, Dept Pathol & Clin Labs, Showa Ku, 65 Tsururnai Cho, Nagoya, Aichi 4668560, Japan
[2] Nagoya Med Ctr, Dept Pathol, Nagoya, Aichi, Japan
[3] Okayama Univ Hosp, Dept Pathol, Okayama, Japan
[4] Toyota Mem Hosp, Dept Pathol, Toyota, Japan
关键词
Sinonasal glomangiopericytoma; beta-catenin; CTNNB1; LEF1; PERIVASCULAR MYOID DIFFERENTIATION; SOLITARY FIBROUS TUMOR; NUCLEAR EXPRESSION; MIMICS;
D O I
10.1007/s00428-018-2370-9
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Sinonasal glomangiopericytoma (SN-GPC) is an uncommon mesenchymal tumor with myoid differentiation. Recently, mutations in exon 3 of the gene coding for beta-catenin (CTNNB1) and its nuclear expression were discovered in SN-GPC. beta-catenin protein is a key regulatory molecule of the canonical Wnt signaling pathway. The expression of beta-catenin target proteins is not well characterized in SN-GPC. We examined three SN-GPCs by immunohistochemistry and CTNNB1 mutation analysis. All cases expressed nuclear beta-catenin. We identified CTNNB1 exon 3 mutations in two analyzable cases. Lymphoid enhancerbinding factor 1 (LEF1), a protein downstream from beta-catenin, was also expressed in all cases. Our results further characterized the activation of the Wnt signaling pathway caused by CTIVNB1 exon 3 mutation and suggest the utility of LEF 1 immunohistochemistry in the differential diagnosis of SN-GPC.
引用
收藏
页码:235 / 239
页数:5
相关论文
共 50 条
  • [1] β-catenin (CTNNB1) mutation and LEF1 expression in sinonasal glomangiopericytoma (sinonasal-type hemangiopericytoma)
    Yuka Suzuki
    Shu Ichihara
    Tomonori Kawasaki
    Hiroyuki Yanai
    Satoshi Kitagawa
    Yoshie Shimoyama
    Shigeo Nakamura
    Masato Nakaguro
    Virchows Archiv, 2018, 473 : 235 - 239
  • [2] Pathology Quiz Case 1 Glomangiopericytoma (sinonasal-type hemangiopericytoma [HPC])
    Worden, Brian
    Getz, Anne
    Luo, Robert
    Hwang, Peter H.
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2009, 135 (05) : 520 - +
  • [3] Nuclear expression and gain-of-function β-catenin mutation in glomangiopericytoma (sinonasal-type hemangiopericytoma): insight into pathogenesis and a diagnostic marker
    Lasota, Jerzy
    Felisiak-Golabek, Anna
    Aly, F. Zahra
    Wang, Zeng-Feng
    Thompson, Lester D. R.
    Miettinen, Markku
    MODERN PATHOLOGY, 2015, 28 (05) : 715 - 720
  • [4] Glomangiopericytoma (sinonasal-type hemangiopericytoma): A case report of an unusual neoplasm
    Mitropoulou, G.
    Arkoumani, E.
    Tsavari, A.
    Myoteri, D.
    Koulia, K.
    Vassilakaki, T.
    Manoloudaki, K.
    VIRCHOWS ARCHIV, 2014, 465 : S70 - S70
  • [5] Diagnostic utility of LEF1 and β-catenin in WNT pathway tumors with CTNNB1 mutation
    Li, Can
    Dong, Lingdan
    Zhu, Li
    Guan, Wenbin
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2025, 23 (01)
  • [6] Glomangiopericytoma with CTNNB1 mutation
    Iwata, Shinji
    Kitazawa, Riko
    Kitazawa, Sohei
    Hato, Naohito
    BMJ CASE REPORTS, 2023, 16 (09)
  • [7] CTNNB1 and APC Mutations in Sinonasal Myxoma
    Chen, Sonja
    Gallant, Sara
    Cunningham, Michael J.
    Robson, Caroline D.
    Church, Alanna J.
    Perez-Atayde, Antonio R.
    Al-Ibraheemi, Alyaa
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2023, 47 (11) : 1291 - 1300
  • [8] CD34-Positive Spindle Cell Tumor With CTNNB1 Mutation: An Unusual Spindle Cell Variant of Sinonasal Glomangiopericytoma
    Iwamura, Ryuji
    Nawata, Aya
    Akaike, Ryota
    Kitamura, Takuro
    Hisaoka, Masanori
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2024, 32 (02) : 408 - 413
  • [9] PIK3CA mutation in a case of CTNNB1-mutant sinonasal glomangiopericytoma
    Hong, Christopher S.
    Khan, Mohammad
    Sukys, Jordan M.
    Prasad, Manju
    Erson-Omay, E. Zeynep
    Vining, Eugenia M.
    Omay, Sacit Bulent
    COLD SPRING HARBOR MOLECULAR CASE STUDIES, 2022, 8 (01):
  • [10] Lymphoid enhancer-binding factor 1 (LEF1) immunostaining as a surrogate for β-catenin (CTNNB1) mutations
    Hewer, Ekkehard
    Fischer, Pascal David
    Vassella, Erik
    Knabben, Laura
    Imboden, Sara
    Mueller, Michael D.
    Rau, Tilman T.
    Dettmer, Matthias S.
    JOURNAL OF CLINICAL PATHOLOGY, 2024,